amiodarone


Also found in: Thesaurus, Medical, Wikipedia.
Related to amiodarone: adenosine, amiodarone hydrochloride

a·mi·o·da·rone

 (ə-mē′ō-də-rōn′, -rən)
n.
A vasodilator drug, C25H29I2NO3, used in its hydrochloride form to control ventricular and supraventricular arrhythmias and to manage angina pectoris.

ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.amiodarone - an antiarrhythmic drug (trade name Cordarone) that has potentially fatal side effects and is used to control serious heart rhythm problems only when safer agents have been ineffectiveamiodarone - an antiarrhythmic drug (trade name Cordarone) that has potentially fatal side effects and is used to control serious heart rhythm problems only when safer agents have been ineffective
antiarrhythmic, antiarrhythmic drug, antiarrhythmic medication - a drug used to treat an abnormal heart rhythm
Translations
Amiodaron

amiodarone

n amiodarona
References in periodicals archive ?
2] /day) per oral for 2 days, and amiodarone (5 mg/kg) intravenously were tried during transcatheter temporary ventricular pacing.
Dronedarone, which will be marketed as Multaq, is similar to amiodarone, but is not associated with the older agent's pulmonary and thyroid toxicity.
Amiodarone is a class III antiarrhythmic drug widely used for both ventricular and supraventricular tachyarrhythmias.
After a loading dose of amiodarone he continued on 200 mg daily, and remained in sinus rhythm.
Despite several attempts of cardioversion and two ablations, my heart went from alternating between normal rhythm and A-fib to constant A-fib despite massive dosages of Toprol-XL and amiodarone.
Amiodarone is a widely prescribed anti-arrhythmic for atrial and ventricular arrhythmias.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that more than 70 percent of surveyed cardiologists and 60 percent of surveyed managed care organizations' (MCOs) pharmacy directors consider amiodarone (Sanofi-Aventis's Cordarone, generics) to be the most effective antiarrhythmic drug for maintaining normal sinus rhythm (NSR) in patients with atrial fibrillation.
today announced that the recently-completed Phase 3 European Comparator Study (the AVRO study) evaluating vernakalant (iv) versus amiodarone for the acute conversion of atrial fibrillation met its primary endpoint.
In in vitro studies, amiodarone treatment has been shown to inhibit the release of TNF-[alpha] and IL-6 from the peripheral mononuclear cells stimulated with lipopolysaccharides (9).
An FDA panel recommended 10-3 that dronedarone, an analogue of amiodarone, be approved for treating patients with nonpermanent atrial fibrillation, with recommendations that the label include a boxed warning cautioning against use of the drug in patients with hearth failure.
A case of torsades de pointes is reported following administration of amiodarone concurrent with the fluoroquinolone levofloxacin.
Abstract: Amiodarone is increasingly prescribed for patients with ventricular and supraventricular tachyarrhythmias.